BAZ2B Gene Down-Regulation for Aging and Cognitive Decline
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The aging process is associated with significant physiological declines and increased risk of neurodegenerative diseases like Alzheimer's, with unclear regulatory mechanisms of gene expression changes, necessitating the identification of genes that can serve as targets for alleviating aging and related diseases.
Innovation Solution
Utilizing the BAZ2B gene as a target, employing down-regulators such as gene editing reagents, interfering molecules, or antibodies to inhibit BAZ2B protein or encoding gene expression, thereby alleviating aging and related diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If BAZ2B gene expression is down-regulated to alleviate aging, then mitochondrial function improves and cognitive abilities enhance, but the mechanism of gene expression regulation during aging remains unclear
Solution Approach 1:
The patent uses epigenetic regulatory factors as intermediaries to link environmental factors with cell signaling pathways, thereby elucidating the regulatory mechanism of BAZ2B gene expression during aging. This mediator approach allows researchers to understand how external factors influence gene expression without directly observing the complex molecular interactions.
Solution Approach 2:
The patent employs feedback mechanisms by using epigenetic molecules to regulate gene expression, which in turn affects cellular function and aging processes. This creates a regulatory loop where gene expression changes can be monitored and controlled through epigenetic modifications, providing a measurable feedback system for studying aging mechanisms.
2Duration of action of stationary object
If epigenetic regulatory factors are used to link environmental factors with cell signaling pathways, then lifespan regulation in model animals is achieved, but the specific regulatory mechanism and how expression changes lead to behavioral deterioration remain unclear
Solution Approach 1:
Epigenetic regulatory factors serve as intermediaries between environmental factors and cell signaling pathways, enabling the study of lifespan regulation without directly observing the complex molecular mechanisms. This intermediary approach allows for measurable effects on lifespan while the underlying mechanisms remain investigable through epigenetic markers.
Solution Approach 2:
The patent replaces direct observation of complex molecular mechanisms with epigenetic modifications as a proxy system. By measuring epigenetic changes (DNA methylation, histone modification) instead of directly tracking molecular interactions, the research can study lifespan regulation and behavioral deterioration through more accessible and measurable epigenetic markers.
3Object-affected harmful factors
If gene editing reagents are used to knock out BAZ2B encoding gene, then specific inhibition of BAZ2B is achieved, but device complexity increases
Solution Approach 1:
The patent extracts and targets the specific BAZ2B gene for inhibition using gene editing reagents. By focusing on removing or disabling only the problematic BAZ2B gene expression while leaving the rest of the genome intact, the approach eliminates the harmful effects of BAZ2B overexpression with minimal disruption to overall system complexity.
Solution Approach 2:
The gene editing reagents are designed to act locally and specifically on the BAZ2B gene sequence, affecting only the target gene rather than causing widespread genomic changes. This localized action reduces the complexity burden by limiting the scope of genetic modification to precisely what is needed for therapeutic effect.
Data Source
AI summary
Provided is an application of a BAZ2B gene as a target in slowing aging. It is disclosed that the BAZ2B gene plays an important regulatory role in occurrence and development of normal aging and age-related diseases, and the down-regulation thereof can significantly slow aging and alleviatememory decay, capacity degradation and the like in the aging process. The BAZ2B can be used as the research target of aging and age-related diseases for developing drugs of inhibiting or delaying aging, and used as a diagnostic and prognostic marker of aging and age-related diseases.